Oarsman Capital, Inc. Clear Point Neuro, Inc. Transaction History
Oarsman Capital, Inc.
- $562 Million
- Q4 2024
A detailed history of Oarsman Capital, Inc. transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Oarsman Capital, Inc. holds 5,000 shares of CLPT stock, worth $65,350. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$65,350
Previous $56,000
35.71%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
93Shares Held
7.57MCall Options Held
390KPut Options Held
28.7K-
Vanguard Group Inc Valley Forge, PA1.25MShares$16.3 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA509KShares$6.65 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA409KShares$5.34 Million1.22% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.79 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$4.36 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $320M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...